SINGAPORE – Media OutReach Newswire – 27 February 2026 – DEEBOT T90 PRO OMNI features a suite of fully upgraded technologies that deliver a truly hands-free and ultra-powerful experience, setting a new standard in the mid-range robotic vacuum market. Integrating advanced innovations such as OZMO ROLLER 3.0 and PowerBoost Technology within an exclusive minimalist Nordic design, the T90 PRO OMNI offers a top-of-the-line, premium floor cleaning experience and delivers the best value in its class.
OMNI Station features Fresh-flow Power Washing and Dirty Water Box Auto-Cleaning so users no longer have to clean the machine manually. AGENT YIKO uses intelligent scene recognition to detect cleaning zones and avoid pets while cleaning.
ECOVACS ROBOTICS, a pioneer in service robotics, introduces the DEEBOT T90 PRO OMNI – an all-new generation of hands-free, ultra-powerful robotic cleaning built on fully upgraded technologies. Powered by the new OZMO ROLLER 3.0 Instant Self-Washing Mopping Technology and PowerBoost Technology with Perpetual Runtime, the T90 PRO OMNI ensures spotless results with zero interruptions, creating a daily life with a calm, Nordic-inspired aesthetic that naturally blends into your home and daily life.
Elevated mopping performance with the new OZMO ROLLER 3.0 Instant Self-Washing Mopping Technology. TruEdge 3.0 Extreme Edge Cleaning that reaches into hard to clean edges while protecting furniture.
With the DEEBOT T90 PRO OMNI, ECOVACS redefines what mid-range robotic vacuum cleaners can achieve. This new addition brings together premium cleaning performance, long-lasting reliability, and a seamless design that effortlessly fits into contemporary homes. Delivering top-tier results with class-leading value, the T90 PRO OMNI sets a new benchmark for what consumers can expect from the mid-range segment.
Spotless Cleaning, Perpetual Runtime
The DEEBOT T90 PRO OMNI elevates mopping performance with the fully upgraded OZMO ROLLER 3.0 Instant Self-Washing Mopping Technology. A 50% longer 27-cm roller covers more floor area in each pass, while a high-performance pressurized water pump feeds 16-nozzle 32-way precision nozzles to tackle stubborn messes. The roller spins at up to 200 RPM to prevent streaks and secondary contamination, keeping floors consistently spotless with no manual scrubbing required.
Equipped with the revolutionary PowerBoost Technology that redefines intelligent charging for robotic vacuum cleaners, the DEEBOT T90 PRO OMNI showcases ECOVACS’ latest leap in cleaning efficiency through ultra-fast energy boosts and non-stop cleaning freedom. A self-optimizing algorithm dynamically reserves power to prioritize full-space completion, enabling 10% battery power to be restored in three minutes during routine mop cleaning intervals, and up to 500 m² can be cleaned in a single run without interruption. This intelligence-driven, perpetual operation ensures that even large homes stay clean in a single cycle – no need to worry about a low battery or incomplete tasks.
Total Home Coverage, Unstoppable Clean
The fully upgraded TruEdge 3.0 Extreme Edge Cleaning ensures edge-to-edge cleanliness. Its 1.5 cm air-cushion suspended roller adapts in real time to glide smoothly along walls, while a protective felt strip prevents scratches to furniture and baseboards. Two soft rubber edge-gliding wheels and a fixed side brush further extend cleaning reach, capturing hidden debris that typical vacuums leave behind.
When facing impassable obstacles, the TruePass Adaptive 4-Wheel-Drive Climbing System gives the DEEBOT T90 PRO OMNI unmatched mobility. Two auxiliary levering wheels deploy automatically when needed, using soft rubber gripping teeth to climb single steps up to 2.4 cm and consecutive steps up to 4 cm. This ensures the robot cleans seamlessly across uneven surfaces without missing rooms or getting stuck.
The all-new ZeroTangle 4.0, with lateral airflow channels, and a reinforced wide-span dual-bearing structure, captures dust and hair efficiently without tangling. This reduces maintenance and keeps suction strong and stable, giving users a smooth, quiet, and worry-free cleaning experience every day.
Elegant Design Meets Effortless Maintenance
Understanding consumers’ desire for both style and convenience, ECOVACS designed the DEEBOT T90 PRO OMNI with a refined, minimalist aesthetic inspired by Nordic design. Its monochromatic point-cloud texture and fabric-like finish offer a warm, premium appearance while ensuring durability and easy upkeep, effortlessly complementing any home interior.
To make cleaning truly hands-free, the OMNI Station features Fresh-flow Power Washing and Dirty Water Box Auto-Cleaning. Fresh-flow Power Washing uses a new high-pressure direct pump to deliver heated water (up to 75°C) through 16 nozzles, saturating and deep-cleaning the mop roller for maximum cleanness. The self-cleaning wastewater system — with a 5,000 RPM propeller, straight-down drainage, a dual-layer scraping mechanism, and an independent sediment trough — removes dirt quickly to eliminate odors and prevent contamination. Users can enjoy a consistently fresh cleaning experience without touching dirty components.
An AI-Powered Experience that Truly Understands You and Your Home
With AGENT YIKO, the DEEBOT T90 PRO OMNI becomes more than a cleaning device — it is an intelligent home companion. Using intelligent scene recognition, AGENT YIKO identifies room types, floor materials, and pet zones, then automatically generates adaptive cleaning plans based on your habits and living space. It adjusts suction, water flow, and route planning in real time to deliver optimal results with zero management.
For pet families, the T90 PRO OMNI offers a gentle yet smart cleaning experience. It can sense and avoid pets while they roam. Users can set customized pet activity zones, so the robot focuses where it’s needed most, keeping both floors and furry friends happy.
Whether you’re at home or away, you can count on a spotless space, a healthier environment, and a cleaning experience that fits naturally into your lifestyle.
DEEBOT T90 PRO OMNI and DEEBOT mini 2 Debut at the Singapore IT Show 2026
Marking their first public showcase in Singapore, the DEEBOT T90 PRO OMNI and the DEEBOT mini 2 will officially debut at the Singapore IT Show 2026, taking place from 12 to 15 March 2026. Visitors to the show will be among the first in Singapore to experience ECOVACS’ latest DEEBOT T90 PRO OMNI launch in person, with live demonstrations highlighting its upgraded OZMO ROLLER 3.0 Instant Self-Washing Mopping Technology and PowerBoost Technology with Perpetual Runtime, as well as the refined Nordic-inspired design.
Consumers will also be able to experience the new ultra-compact DEEBOT mini 2, for those seeking a powerful cleaning solution without compromising on space. With a diameter of just 28.6 cm – smaller than a sheet of A4 paper – the DEEBOT mini 2 is designed for small apartments, from compact studios to two-bedroom homes. Despite its size, the DEEBOT mini 2 is equipped with advanced technologies like TrueMapping 2.0 and TrueDetect 3D, to plan cleaning routes and detect different surfaces, providing up to 91% whole-home cleaning coverage. It effortlessly navigates tight corners and hard-to-reach areas, offering 100% edge and corner coverage. Whether it’s under coffee tables, between furniture legs, or in narrow hallways, the DEEBOT mini 2 ensures that no spot is left behind.
The showcase underscores ECOVACS’ commitment to bringing intelligent, hands-free home cleaning innovations closer to local consumers through immersive, hands-on experiences.
Pricing and Availability
The DEEBOT T90 PRO OMNI and DEEBOT mini 2 will be available in Singapore from 8PM on 2 March 2026via the ECOVACS official webstore, NTUC FairPrice webstore, Shopee, Lazada, and TikTokShop.
The DEEBOT T90 PRO OMNI will be offered at a pre-sale price of S$1,199 (U.P. $1,899). Purchases made on the official webstore, Fairprice Online, Shopee, Lazada, and Tiktok will include a Tineco iCarpet Spot Cleaner worth S$379, while stocks last.
The DEEBOT mini 2 will be offered at a pre-sale price of S$599 (U.P. $749). Purchases made on the official webstore, Fairprice Online, Shopee, Lazada, and Tiktok will include an accessories pack worth S$48.90, while stocks last.
Hashtag: #ECOVACS
The issuer is solely responsible for the content of this announcement.
About ECOVACS ROBOTICS:
Founded in 2006, ECOVACS ROBOTICS is a global leader in home service robotics with a diverse portfolio of products encompassing robotic vacuum cleaners and robotic window cleaners. With its expansion into robotic lawn mowers, commercial cleaning robots and robotic pool cleaners, ECOVACS solidified its position as a multi-category leader in home service robotics.
Guided by the mission “Robotics for All”, ECOVACS continues to advance technology and enhance the user experience to make life smarter and more stylish for consumers worldwide. With sales subsidiaries in Germany, the United States, Japan, and Singapore, ECOVACS products reach nearly 180 major markets and serve over 38 million households globally.
A testament to this market leadership, ECOVACS ROBOTICS has ranked first in China’s robotic vacuum cleaner market by share for ten consecutive years (2015-2024).
DONGGUAN, China, Feb. 27, 2026 /PRNewswire/ — QCY, a leader in high-performance wearables, is taking athletes’ fitness to the next level with the QCY Track, the ultimate sports smartwatch built for precision, power, and endurance. Packed with cutting-edge features, this game-changing device is designed to keep athletes at the top of their game, whether they are training, competing, or pushing their limits.
QCY Track S10
Precision Performance Tracking for Superior Results
Equipped with a 1.43-inch HD AMOLED display, an ultra-high 466 × 466 resolution, and 1000-nit peak brightness, the watch ensures crystal-clear visibility whether under intense sunlight or in low-light conditions. From cycling speed and running pace to stroke data in the pool, athletes can rely on real-time, highly accurate metrics to quantify every session and fine-tune their performance on the go.
Triathlon-Focused Features for Smarter Training
Specially tailored for outdoor athletes, this watch is engineered to support structured and data-driven training. Its built-in lactate threshold monitoring and dedicated training navigation system provide in-depth insights across swim, bike, and run activities, ensuring each workout is executed at the optimal intensity. With support for over 150 sport modes—from high-intensity interval training (HIIT) to long-distance endurance sessions—it offers real-time performance feedback that keeps users progressing in any environment.
Comprehensive Health Monitoring, Every Moment Covered
Beyond performance metrics, the watch offers a full suite of health-tracking capabilities. Heart Rate Variability (HRV), sleep analysis, and a one-tap health check provide a deep understanding of recovery status and help athletes avoid overtraining. With continuous monitoring, users can adjust their training plans with confidence to ensure peak condition for every workout and race.
Ultra-Long Battery Life to Power Your Longest Races
Triathlon events demand exceptional endurance—not just from athletes but from their gear. This watch delivers up to 19 days of battery life, ensuring uninterrupted support throughout extended training sessions and races. With dual-band, six-system GNSS and offline maps, it provides precise navigation even without network connectivity, guaranteeing smooth performance in any scenario.
Featherlight Build for All-Day Comfort
Despite its powerful feature set, the watch weighs just 37 grams, offering exceptional comfort for long-term wear during training and competition. Its 5ATM water-resistant design ensures reliable performance in the pool and under harsh weather conditions, making it ready for any challenge.
Precision Performance with Elite Hardware
Dual-frequency 6-satellite GNSS for ultra-accurate positioning
Multi-channel heart rate & SpO₂ sensors for all-round health tracking
High-speed eMMC storage for smooth, fast performance
The QCY TRACK S10 will be launched through authorized retailers in March and available in Black and Titanium. To learn more about the QCY TRACK S10 and explore QCY’s full range of audio solutions, please visit www.qcy.com.
About QCY Founded in 2009, QCY is a global leader in smart wearables, dedicated to creating high-quality, affordable, and innovative audio products for everyone. With a focus on creative technology and user-centered design, QCY continues to redefine the way people listen to music, communicate, and connect in their daily lives.
SINGAPORE, Feb. 27, 2026 /PRNewswire/ — Law Wai-Sum, a Hong Kong trader known as J Law, is expanding his investment education business, JLawStock, to Singapore after posting a record 1,499% cumulative return over two years in the top division of the United States Investing Championship.
The move marks the first phase of Law’s broader international expansion, with Singapore serving as the base to engage retail investors seeking more systematic and professional approaches to trading.
A Historic Achievement in a Four-Decade Competition
Founded in 1983 by Norman Zada, then a visiting scholar at Stanford University, the United States Investing Championship tracks verified real-money accounts and publishes audited performance rankings across multiple divisions. Over the past four decades, participants have included hedge fund managers such as Paul Tudor Jones and Louis Bacon, as well as trading legends including David Ryan and Mark Minervini.
According to official results, Law won the $1 million-plus stock division with a 353.9% return in 2024, followed by a 252.3% gain in 2025, becoming the first Asia-based trader to secure consecutive titles in the top-tier category.
His combined two-year return of 1,499% set a new record for the division. Over the same period, the S&P 500 gained about 47%, as noted by the competition organizers.
Law Picks Singapore as Hub for Education Expansion
Following a record two-year performance in trading competition, Law is expanding his investment education business and positioning Singapore as the regional hub for JLawStock.
JLawStock offers structured trading frameworks for retail investors. Its curriculum emphasizes professional trading techniques, discipline and the mindset required for long-term market participation. The programs have attracted full-time traders, financial influencers, and fund managers.
As part of its global growth strategy, the firm is establishing Singapore as its regional base and has launched an English-language YouTube channel aimed at a broader international audience.
Law described Singapore as a leading asset- and wealth-management center with a regulatory framework that supports structured investment practices.
“Singapore is a global capital hub where investors value discipline and process,” he said. “The regulatory environment and the sophistication of the financial ecosystem are aligned with JLawStock’s long-term mission.”
He said the objective is to translate trading methodologies developed in U.S. markets into practical educational frameworks for retail investors in the region.
Expanding Access to a Champion-Level Framework
Against a backdrop of elevated global market volatility, Law said financial literacy and risk management are becoming increasingly important for retail investors participating in international equities.
In Singapore, he plans to introduce his trading framework, the Multiple-Edge Trading Strategy, or M.E.T.S., a rules-based system that integrates price-structure analysis, capital allocation, trading discipline and market psychology, with risk control at its core. The goal, he said, is to make the approach accessible to a broader base of investors and traders seeking to improve consistency.
“Most people focus on finding a magic strategy,” he said. “What makes performance repeatable is a process that reduces costly mistakes and puts risk control first.”
Law, who trades U.S. markets from Asia, also said time differences are not the primary challenge.
“Time zones aren’t the real issue — emotional trading is,” he said. “Success depends on preparation and identifying favorable risk-reward setups before the opening bell.”
Looking ahead, Law said he is exploring potential partnerships with Singapore-based fintech firms and licensed brokerages as part of the expansion, aimed at broadening access to structured trading education for retail participants in global markets.
About the United States Investing Championship
Founded in 1983, the United States Investing Championship is a real-money investing competition that tracks participants’ performance across multiple divisions and publishes annual standings.
About J Law (Law Wai-Sum)
J Law is a two-time world champion of the United States Investing Championship ($1,000,000+ Stock Division). He holds the competition’s all-time two-year cumulative return record of +1,499%, achieved through verified real-money trading. As a pragmatic investment educator, J Law specializes in systematic market analysis and risk management. He runs widely popular investment channels, aiming to share world-class trading psychology and frameworks with a global audience.
Disclaimer: This release is for informational and educational purposes only and does not constitute personalized investment advice. Past performance does not guarantee future results.
BARCELONA, Spain, Feb. 27, 2026 /PRNewswire/ — vivo today announced its attendance at Mobile World Congress 2026 (MWC 2026), taking place in Barcelona from March 2 to 5. At the event, vivo will offer the first global preview of its upcoming flagship, the X300 Ultra, and present its key conference message for the future of mobile innovation under the theme “Where Vision Meets.”
vivo’s debut at MWC marks a strategic milestone in its evolution as a global technology leader, reflecting the company’s commitment to deepening its global presence and advancing its premium portfolio. As one of the world’s most influential platforms for mobile technology, MWC offers vivo a global stage to engage with international media, industry leaders, operators, and partners, while demonstrating its long-term commitment to high-end innovation.
At the center of vivo’s MWC 2026 showcase will be the preview of the X300 Ultra, providing an early look at vivo’s latest premium design language and imaging advancements.
The X300 Ultra represents vivo’s most advanced exploration to date in mobile imaging and videography, building on the company’s continued investment in optics engineering, computational photography, and system-level optimization.
Visitors to the vivo booth will experience the uniquely inspired design of the X300 Ultra, drawn from the company’s professional imaging heritage. In addition, vivo will showcase a broader lineup of products at MWC 2026, including the X300 Series, vivo X Fold5, V70 Series, with hands-on demonstrations to illustrate how advanced technologies in imaging, AI, and system performance translate into intuitive, human-centered experiences.
vivo’s presence at MWC 2026 underscores its steadfast commitment to engaging more deeply with the global mobile ecosystem and competing at the forefront of the premium segment. By bringing together product innovation, refined design, and ecosystem collaboration, vivo aims to demonstrate how technology can enhance perception, expression, and connection in everyday life.
About vivo
vivo is a technology company that creates great products based on a design-driven value, with smart devices and intelligent services as its core. The company aims to build a bridge between humans and the digital world. Through unique creativity, vivo provides users with an increasingly convenient mobile and digital life. Following the company’s core values, which include Benfen*, user-orientation, design-driven value, continuous learning and team spirit, vivo has implemented a sustainable development strategy with the vision of developing into a healthier, more sustainable world-class corporation.
While bringing together and developing the best local talents to deliver excellence, vivo is supported by a network of R&D centers in Shenzhen, Dongguan, Nanjing, Beijing, Hangzhou, Shanghai, Xi’an and more cities, focusing on the development of state-of-the-art consumer technologies, including 5G, artificial intelligence, industrial design, imaging system and other up-and-coming technologies. vivo has also set up an intelligent manufacturing network (including those authorized by vivo), with an annual production capacity of nearly 200 million smartphones. As of now, vivo has branched out its sales network across more than 60 countries and regions, and is loved by more than 500 million users worldwide.
*”Benfen” is a term describing the attitude on doing the right things and doing things right – which is the ideal description of vivo’s mission to create value for society.
HONG KONG, Feb. 27, 2026 /PRNewswire/ — On 23 February 2026, The Hong Kong Management Association (HKMA) held the 2025 HKMA Best Annual Reports Awards presentation ceremony in Hong Kong. Fosun International received the “Certificate of Excellence in Environmental, Social and Governance Reporting”, underscoring the company’s outstanding performance in ESG strategy, environmental protection, social responsibility, corporate governance and information disclosure, and its continued recognition by industry authorities.
Since its inception in 1973, the HKMA Best Annual Reports Awards has become a highly regarded benchmark in Hong Kong’s information disclosure landscape. It aims to award and recognize organizations for their achievement in annual report preparation.
A total of nine enterprises received the “Certificate of Excellence in Environmental, Social and Governance Reporting”. Other award-winning companies include CLP Holdings, CK Hutchison Holdings, Hong Kong Exchanges and Clearing Limited, MTR Corporation, Swire Properties, Chow Tai Fook Jewellery, S.F. Holding, Lenovo Group, and The Hongkong and Shanghai Hotels, all of which are prominent blue-chip listed companies.
HKMA pointed out that the award-winning companies have significantly enhanced ESG governance by incorporating ESG into their long-term development strategies and key future initiatives. They also align with international climate-related information disclosure standards such as the Task Force on Climate-related Financial Disclosures (TCFD), while demonstrating management’s active engagement and strong commitment to ecosystems and biodiversity.
In 2023, Fosun established the “Create IMPACT” sustainable development strategy, built on six key pillars: Innovation-driven, Mindful Operation, People and Partner Oriented, Advanced Governance, Climate and Planet Positive and Transparency, to systematically integrate ESG principles into its business strategy.
I: Innovation-driven
M: Mindful Operation
P: People and Partner Oriented
A: Advanced Governance
C: Climate and Planet Positive
T: Transparency
Since its establishment in 1992, Fosun has developed into a global innovation-driven consumer group with businesses in more than 40 countries and regions. With the original aspiration of “Self-improvement, Teamwork, Performance, and Contribution to Society”, Fosun remains committed to developing business for good. While advancing robust business development, Fosun continuously optimizes its sustainable development strategy to address profound shifts in the global economy, society, and environment, ensuring long-term competitiveness alongside social value creation.
Actively responding to climate change and promoting low-carbon transformation
In response to climate change challenges, the Group has transitioned from passive adaptation to proactive participation and innovation. At top-level governance, under the coordination of the Board of Directors (the “Board”) and the Carbon Neutrality Committee, Fosun has achieved several key milestones, such as incorporating carbon neutrality indicators into the performance appraisal of the management, establishing a carbon emission management system and audit standards, and conducting greenhouse gas inventory training across the Group. In terms of technology-driven low-carbon transformation, the Group has accelerated the adoption of low-carbon technologies, leveraging innovative approaches to drive green transformation across its industrial chain and continuously provide sustainable products and services to consumers. In terms of financial innovation, In September 2025, Fosun held the signing ceremony in Hong Kong for its three-year sustainability-linked syndicated loan. The total syndicated amount was further increased to USD990 million equivalent, setting a new record for the largest offshore syndicated loan by a Chinese private enterprise in 2025. This achievement has effectively supported the implementation of the Group’s sustainable development strategy.
Fosun actively responds to the national “dual carbon” goals by promoting carbon neutrality, energy conservation and emission reduction. In 2021, Fosun made a commitment to society – “strive to peak carbon emissions by 2028 and achieve carbon neutrality by 2050”. Fosun has formulated strategies for climate change mitigation and adaptation in support of the Paris Agreement’s global temperature control framework. As Hong Kong Stock Exchange’s New Climate Requirements came into effect in 2025, Fosun International further aligned with the International Financial Reporting Standards S2 Climate-related Disclosures Requirements (IFRS S2) and TCFD recommendations, and released its third Climate Information Disclosures Report, continuously enhancing the transparency of its climate initiatives and demonstrating its steadfast long-term commitment.
The Group also actively encourages its member companies to carry out climate actions. In 2022, the Bund Finance Center (BFC), Fosun’s base in Shanghai, was awarded the LEED Platinum certification, which is hailed as the “Oscar Award” in the green building industry, with a score of 97 points to set a new world record. In August 2024, BFC was successfully included in Shanghai’s first batch of carbon peaking and carbon neutrality pilot demonstration projects, making it the only large-scale commercial complex exceeding 200,000 square meters on the list.
During the 29th session of the Conference of the Parties (COP29), Fosun Insurance Portugal (Fidelidade), a member company of Fosun, launched the Impact Center for Climate Change (ICCC), a platform for the study, research and sharing of knowledge with society, to drive innovation in climate risk knowledge and enhance the insurance industry’s climate resilience. In February 2026, the ICCC held its annual Climate Research and Industry Exchange Conference, unveiling Portugal’s first innovative study on forest fire risks to translate climate science into practical insurance risk management.
Actively driving global sustainable development and achieving outstanding ESG ratings
With a focus on core business development, Fosun leverages its comprehensive global industrial ecosystem to conduct responsible operations across more than 40 countries and regions, continuously contributing to public welfare and creating sustainable value worldwide. In addition, Fosun has long been committed to philanthropy in areas such as rural revitalization, healthcare, educational equity, community building, culture and art, steadily expanding its community impact and striving to build a more responsible, inclusive and sustainable future.
As a responsible global citizen, Fosun officially joined the United Nations Global Compact (“UN Global Compact”) in 2014. It fully supports the ten principles of the UN Global Compact on human rights, labor, environment and anti-corruption, and has deeply integrated these principles into the Group’s sustainable development strategy and code of conduct. Despite persistent global macroeconomic uncertainties, Fosun remains steadfast in advancing its sustainable development, fulfilling its long-term commitments on key issues and earning continued international recognition.
Fosun International’s ongoing efforts have earned growing recognition from international rating agencies for its ESG management. Fosun has been included in the FTSE4Good Index Series for five consecutive years and has maintained its HSI ESG rating at AA-. In 2025, Fosun’s FTSE Russell ESG score rose to 4.2. It also ranked in the top 5% among global peers in S&P Global’s Corporate Sustainability Assessment (CSA), was included in S&P Global’s Sustainability Yearbook 2025 (Global Edition), and was selected as the top 1% in S&P Global’s Sustainability Yearbook (China Edition).
MELBOURNE, Australia, Feb. 27, 2026 /PRNewswire/ — RateMyAgent, Australia’s leading review and ratings platform, has officially announced the winners of the 2026 Agent of the Year Awards. This year’s winners represent the elite echelon of the property industry, with the nominee pool accounting for a staggering $85.8 billion in total sale value over the 2025 calendar year.
Now in its eleventh year, the awards are the only industry honors determined by verified customer feedback rather than just sales volume. The 2026 results were fueled by over 140,000 verified reviews received on the platform over 2025. The 2026 winners were calculated using a rigorous process independently reviewed by global accounting firm RSM to ensure total transparency and fairness.
The gala event, held at Melbourne’s Glasshouse and hosted by Andrew Gill, brought together the country’s elite property professionals, featuring keynote insights from RateMyAgent CEO Jim Crisera and Domain Sales Director Damien Brooks.
“These awards aren’t about who has the biggest marketing budget; they are about who provides the best experience for Australian homeowners,” said RateMyAgent CEO Jim Crisera. “By focusing on verified feedback, we empower consumers to move forward with confidence, knowing they are working with a trusted expert in their local market.”
With the 2026 property market facing unique shifts in interest rates and supply, the role of a trusted local expert has never been more critical. This year’s winners represent the top 1% of the industry who have consistently raised the bar for service excellence.
RateMyAgent (ASX: RMY) helps homeowners select trusted real estate professionals. Operating in the United States of America, Australia and New Zealand, RateMyAgent continues to lead the global market in championing agents that are dedicated to exceptional client service.
RateMyAgent is the consumer-facing platform of the Renowned brand. Renowned is the real estate industry’s first fully integrated Local Expert Marketing (LEM) solution. Renowned turns verified reviews, past performance, listings, and hyperlocal insights into content that wins trust and builds agent reputation across the digital channels that matter most.
Renowned is used by over 350,000 agents and over 11,000 real estate offices worldwide.
TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data demonstrates its accuracy in detecting rare genetic diseases
40% increase in output to 35 billion reads, up to Q70 quality scores, improved turnaround time, and staggered starts are among the updates to be rolled out on all NovaSeq X systems, advancing precision medicine and delivering compounded value for NovaSeq X customers
At AGBT, researchers reveal new findings from studies leveraging Illumina’s multiomics solutions
SAN DIEGO, Feb. 27, 2026 /PRNewswire/ — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a suite of powerful advancements that will significantly accelerate the next era of genomic discovery. Unveiled at the Advances in Genome Biology and Technology (AGBT) 2026 conference, the announcements include the launch of TruPath™ Genome, a new standard in genomic insight; a groundbreaking roadmap for the NovaSeq X Series; and new partner-driven cancer breakthroughs powered by Illumina’s spatial and multiomic technologies.
TruPath Genome, a new standard in genomic insight
Illumina’s launch of TruPath™ Genome sets a new standard for high-quality, comprehensive whole genome insights for genetic disease. TruPath Genome has been found to deliver unparalleled accuracy and resolution – even across so-called “dark regions” of the genome – providing researchers with a more complete picture of genomic alterations implicated in genetic disease.
With an incredibly simple workflow, TruPath Genome eliminates traditional library prep. In just 10-15 minutes of hands-on time, TruPath Genome generates 16 whole genomes per day, nearly double the throughput of competing long-read methods, and with fewer errors.
TruPath Genome leverages novel on-flow cell library preparation with patterned flow cell technology and advanced informatics to seamlessly add long-distance insights for comprehensive variant detection. DRAGEN™ algorithms tuned to incorporate proximity information from TruPath flow cells improve read alignment and variant calling, extending Illumina high quality reads to difficult-to-map regions, variant phasing, structural variants, short tandem repeats (STR), and clinically relevant paralogous genes. TruPath Genome fully phases up to 98% of genes.
The TruPath Genome launch was unveiled during the Gold Sponsor Workshop at the AGBT annual meeting in Orlando. Register here for the replay. For more detailed information on this announcement, please see the press release here, and learn more about TruPath Genome here. TruPath Genome was previously referred to as “constellation mapped read technology”.
Roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility
Building on the revolutionary NovaSeq™ X Series, Illumina unveiled an 18-month roadmap of innovations that enhance the power and value of the NovaSeq X system. Updates include technology that will deliver up to a Q70 quality score for the first time, along with 30% increased speed and output up to 35 billion reads (35B). Staggered starts and new flow cells go live across the customer base in the coming weeks.
Together, these advances increase daily sequencing productivity and expand the range of applications that can be run at scale on a single instrument. With higher output, increased accuracy, faster run times, and new flexible workflow modes, the roadmap delivers compounded value for customers seeking better, faster, and more cost-effective sequencing for their most demanding applications. Improved accuracy ushers in a new era for applications that require ultrasensitivity. Upon rollout, these updates will enhance the performance and value of the 890 NovaSeq X systems installed globally—the world’s largest high-throughput sequencing fleet.
These advances—together with a growing portfolio of multiomic and oncology-focused assays—accelerate Illumina’s ability to deliver higher-quality data at a lower total cost. The updates also set the company on track to scale access to whole-genome sequencing research in oncology, including highly sensitive molecular residual disease (MRD) testing, and genetic disease.
For more detailed information on this announcement, please see the press release here, and learn more about the NovaSeq X here.
Going beyond the genome to advance cancer research using spatial transcriptomics, epigenomics, and proteomics
Illumina and its partners are pushing the boundaries of oncology, powered by Illumina’s spatial transcriptomics, 5-base sequencing, and proteomics technologies. The ability to combine more than one omic insight reveals unprecedented biological depth and knowledge, all of which is streamlined by Illumina Connected Multiomics for multimodal data analysis. The combined portfolio delivers new insights for precision diagnostics, targeted therapeutics development, and understanding of tumor microenvironments.
“Unlocking the human genome has changed the face of cancer care and opened up demand for the next wave of biological insights,” said Jacob Thaysen, chief executive officer at Illumina. “Researchers are rapidly adopting multiomics and informatics technologies that expand our understanding of biology at scale. Illumina’s streamlined multiomics workflows are enabling customers to achieve game-changing breakthroughs in oncology, pharmacogenomics, and more.”
For more detailed information on this announcement, please see the press release here, and learn more about Illumina’s activity at AGBT here.
Use of forward-looking statements This release may contain forward-looking statements that involve risks and uncertainties. Among the important factors to which our business is subject that could cause actual results to differ materially from those in any forward-looking statements are: (i) our ability to successfully implement NovaSeq X updates on a cost-effective and timely basis; (ii) challenges inherent in researching, developing and launching new products, services and technologies, including modifying and scaling manufacturing operations, and reliance on third-party suppliers for critical components; (iii) our ability to manufacture robust instrumentation and consumables and develop reliable software solutions; (iv) the acceptance and adoption by customers of our newly launched or updated products, which may or may not meet our and their expectations; (v ) our ability to deploy new products, services, and applications, and to expand the markets for genomics-related products and services, and together with other factors detailed in our filings with the Securities and Exchange Commission, including our most recent filings on Forms 10-K and 10-Q, or in information disclosed in public conference calls, the date and time of which are released beforehand. We undertake no obligation, and do not intend, to update these forward-looking statements, to review or confirm analysts’ expectations, or to provide interim reports or updates on the progress of the current quarter.
About Illumina Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit illumina.com and connect with us on X, Facebook, LinkedIn, Instagram, TikTok, and YouTube.
SUZHOU, China, Feb. 27, 2026 /PRNewswire/ — Intravesical BCG is the standard of care (SOC) for BCG-naïve high-risk non-muscle-invasive bladder cancer (NMIBC) patients. However, the scarcity of BCG products has become a global phenomenon, and coupled with the side effects of BCG therapy itself, means that a substantial number of patients cannot access effective BCG treatment. Therefore, it is essential to seek better alternative therapies to BCG in order to meet clinical needs. Based on this, ImmVira Group is further expanding the clinical trial of its core oncolytic virus product, MVR-T3011—originally targeting BCG-unresponsive high-risk bladder cancer—to further include BCG-naïve bladder cancer patients.
On February 26, 2026, at the ASCO GU 2026 Conference in San Francisco, California, ImmVira Group announced preliminary positive results from its clinical trial evaluating MVR-T3011, an oncolytic virus, in BCG-naïve high-risk papillary Ta/T1 NMIBC patients for its leading oncolytic virus product, MVR-T3011, via intravesical administration. The data were presented in a poster at the Conference.
In the study involving 18 BCG-naïve high-risk papillary Ta/T1 NMIBC patients treated with intravesical MVR-T3011 at two dose levels: 2×109 PFU (3 patients) and 1×1010 PFU (15 patients), preliminary data as of December 31, 2025, demonstrated encouraging efficacy and durability. Among the 14 evaluable patients, the 12-month recurrence-free-survival (RFS) rate was 100% (3/3) at the 2×109 PFU dose level. At the 1×1010 PFU dose level, the 3-month RFS rate was 100% (11/11). The 6-month and 9-month RFS rates were 75% (3/4) and 66.7% (2/3), respectively, but these data are preliminary, given the small patient numbers reaching those timepoints.
Consistent with BCG-unresponsive clinical data, MVR-T3011 maintained a favorable safety profile in this study with most treatment-emergent adverse events (TEAEs) being at Grades 1 or 2. No treatment-related adverse events (TRAEs) were observed.
Bladder cancer ranks as the ninth most prevalent cancer worldwide[1], with approximately 75% of cases classified as NMIBC. While Bacillus Calmette-Guerin (BCG) remains the current SOC for high-risk NMIBC, global shortages have limited its availability. As a result, oncolytic immunotherapy, which offers enhanced immune activation and potential durability, is emerging as a promising alternative.
“We are highly encouraged by the preliminary efficacy and safety data from the study,” said Dr. Grace Zhou, Chairwoman and CEO of ImmVira. “MVR-T3011 shows its potential to serve as a reliable and widely accessible alternative to BCG, ultimately benefiting patients worldwide.”
Source: 1. GLOBOCAN 2022: Bladder cancer 9th most common worldwide
About MVR-T3011
MVR-T3011, represents a breakthrough in HSV-1-based oncolytic immunotherapy. Its proprietary “3-in-1” design unites a replication-competent, tumor-lytic HSV-1 backbone with anti-PD-(L)1 antibody and IL-12, enabling it simultaneously to lyse tumor cells and stimulate innate and adaptive immunity. MVR-T3011 has demonstrated its adaptability and feasibility across multiple routes of administration including intratumoral, intracavitary and intravenous administrations.
About ImmVira
ImmVira is a clinical-stage biotechnology company that is powered by proprietary biological engineering technology, and is dedicated to the discovery, development, manufacture and commercialization of novel oncolytic immunotherapies and engineered exosome therapies. We have strategically designed, self-discovered, and built a risk-balanced product portfolio that comprised two oncolytic immunotherapy candidates for solid tumors and five engineered exosome assets poised for clinical application or direct commercialization. Driven by our vision to become a global leader in the full spectrum of bladder cancer treatment development and unlock the therapeutical potential of oncolytic immunotherapy in head and neck squamous cell carcinoma (HNSCC), we have adopted a rationalized, adaptive approach to advance oncolytic immunotherapy candidates with high clinical potential globally. In parallel, leveraging our deep expertise in biological engineering, we have pioneered development of engineered exosome candidates targeting chronic, hard-to-treat diseases as well as age-related conditions. These selected engineered exosome assets are being accelerated through differentiated regulatory pathways to enable expedited commercialization and generate sustainable cash flows that will fuel our broader drug development efforts.
